Abbvie Inc (ABBV)

$234.19 +10.26 (4.58%)
Market Cap 405.28B
Revenue (ttm) 56.33B
Net Income (ttm) 4.28B
EPS (ttm) N/A
PE Ratio 24.18
Forward PE 15.85
Profit Margin 7.59%
Debt to Equity Ratio -26.45
Volume 3,301,671
Avg Vol 5,698,778
Day's Range N/A - N/A
Shares Out 1.77B
Stochastic %K 43%
Beta 0.36
Analysts Strong Sell
Price Target $245.81

Company Profile

AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacture, commercialization, and sale of medicines and therapies worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, generalized pustular psoriasis, and pyoderma gangrenosum; Skyrizi to treat autoimmune diseases, erythrodermic psoriasis, generalized pustular psoriasis, and palmoplantar pustulosis; Rinvoq to treat inflammatory diseases; Imbruvica for...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 847 932 7900
Address:
1 North Waukegan Road, North Chicago, United States
cb5000calls
cb5000calls Jan. 7 at 8:12 PM
Speculation: $ABBV buys $RVMD because they already know $PFE has $SLS all but locked up behind closed doors. $XBI
0 · Reply
OptionsKing88
OptionsKing88 Jan. 7 at 8:11 PM
$SLS Abbvie $ABBV is in plans to buy $RVMD and the stock went up by 25% this afternoon. Another clinical stage Oncology company buyout, when is ours. Waiting waiting and still waiting Extremely
0 · Reply
xtremdelt8
xtremdelt8 Jan. 7 at 8:11 PM
$ABBV LOL. Who sold yesterday?
0 · Reply
SparklingGreen
SparklingGreen Jan. 7 at 8:10 PM
$ABBV usually the buyer goes down and the buyee goes up.
0 · Reply
JFais
JFais Jan. 7 at 8:10 PM
$RVMD- known for being a major player in KRAS-driven cancers and specifically pancreatic cancer, +22% on nearing a deal with $ABBV Stock is up 3x since summer lows and nearing a whopping $19 billion market cap Pre-JPM fireworks continues $XBI
0 · Reply
StocktwitsNews
StocktwitsNews Jan. 7 at 8:07 PM
Revolution Medicines Stock Soars On Report Of AbbVie Takeover $RVMD $ABBV https://stocktwits.com/news/equity/markets/revolution-medicines-stock-soars-on-report-of-abbvie-takeover/cmxzObIR42q
0 · Reply
SteeCo
SteeCo Jan. 7 at 8:04 PM
$ALT Biotech heating up. I can’t remember a kick off into the new year with so many takeovers within first days. Even before JPM Things are cooking and biotech in uplift due to such news $TGTX $RVMD $ABBV $SNY https://www.reuters.com/business/healthcare-pharmaceuticals/abbvie-talks-buy-biotech-revolution-medicines-wsj-reports-2026-01-07/
0 · Reply
Runmaster83
Runmaster83 Jan. 7 at 8:03 PM
$ABBV $IBRX $RVMD $XBI Thanks!
0 · Reply
Buzzdaq
Buzzdaq Jan. 7 at 8:02 PM
$ABBV sto Jan30 230cc @ 10.00 (cash raise...)
0 · Reply
OffHisGame88
OffHisGame88 Jan. 7 at 8:01 PM
$ABBV they'll announce the buyout at JP Morgan next week. Word is out on the street
0 · Reply
Latest News on ABBV
AbbVie Near Deal for Revolution Medicines

Jan 7, 2026, 2:48 PM EST - 12 minutes ago

AbbVie Near Deal for Revolution Medicines

RVMD

AbbVie to Host Full-Year and Fourth-Quarter 2025 Earnings Conference Call

Jan 7, 2026, 8:00 AM EST - 7 hours ago

AbbVie to Host Full-Year and Fourth-Quarter 2025 Earnings Conference Call

What Can Trigger A Breakout In Abbvie Stock?

Jan 6, 2026, 11:43 AM EST - 1 day ago

What Can Trigger A Breakout In Abbvie Stock?

Top 3 Health Care Stocks Which Could Rescue Your Portfolio This Month

Jan 6, 2026, 7:29 AM EST - 1 day ago

Top 3 Health Care Stocks Which Could Rescue Your Portfolio This Month

ARGX NBIX

AbbVie to Present at the 44th Annual J.P. Morgan Healthcare Conference

Jan 5, 2026, 8:00 AM EST - 2 days ago

AbbVie to Present at the 44th Annual J.P. Morgan Healthcare Conference

AbbVie: Rocky Near-Term, Positive Long-Term

Jan 4, 2026, 9:04 AM EST - 3 days ago

AbbVie: Rocky Near-Term, Positive Long-Term

My Most Important Warning To Dividend Investors For 2026

Jan 3, 2026, 7:30 AM EST - 4 days ago

My Most Important Warning To Dividend Investors For 2026

AM ARES CNI CPT ENB EPD EXR

AbbVie: Solid Growth, Some Risks, And An Attractive Setup In 2026

Jan 1, 2026, 10:24 PM EST - 5 days ago

AbbVie: Solid Growth, Some Risks, And An Attractive Setup In 2026

Best Dividend Aristocrats For January 2026

Dec 31, 2025, 8:47 AM EST - 7 days ago

Best Dividend Aristocrats For January 2026

ABT ADM ADP AFL ALB AMCR AOS

Best Dividend Kings: December 2025

Dec 28, 2025, 6:44 AM EST - 10 days ago

Best Dividend Kings: December 2025

ABM ABT ADM ADP AWR BDX BKH

Trump to announce new drug-pricing deals later today

Dec 19, 2025, 10:45 AM EST - 19 days ago

Trump to announce new drug-pricing deals later today

AMGN AZN BMY GILD LLY MRK NVO

AbbVie, several other pharma companies near MFN deal with Trump, sources say

Dec 17, 2025, 4:11 PM EST - 20 days ago

AbbVie, several other pharma companies near MFN deal with Trump, sources say

AMGN AZN BMY LLY NVS PFE

Final Trades: Abbvie Inc, Microsoft, Netflix and Twilio Inc

Dec 17, 2025, 2:17 PM EST - 21 days ago

Final Trades: Abbvie Inc, Microsoft, Netflix and Twilio Inc

MSFT NFLX TWLO

AMG Frontier Small Cap Growth Fund: Q3 Sees Strong Outperformance Across Semiconductor Holdings

Dec 14, 2025, 11:30 PM EST - 23 days ago

AMG Frontier Small Cap Growth Fund: Q3 Sees Strong Outperformance Across Semiconductor Holdings

ALGT CGNX COHR EOLS INSP LTH MAT

AbbVie: Unique Mix Of Growth And Value

Dec 10, 2025, 8:01 PM EST - 27 days ago

AbbVie: Unique Mix Of Growth And Value

OSE Immunotherapeutics Announces Strategic Amendment to AbbVie's Partnership on ABBV-230 Development

Dec 8, 2025, 1:30 AM EST - 4 weeks ago

OSE Immunotherapeutics Announces Strategic Amendment to AbbVie's Partnership on ABBV-230 Development

AbbVie Inc. (ABBV) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript

Dec 3, 2025, 4:53 PM EST - 4 weeks ago

AbbVie Inc. (ABBV) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript

AbbVie to Feature New Data at ASH 2025 Showcasing Continued Advances Across Novel Treatment Modalities in Multiple Blood Cancers

Dec 2, 2025, 8:15 AM EST - 5 weeks ago

AbbVie to Feature New Data at ASH 2025 Showcasing Continued Advances Across Novel Treatment Modalities in Multiple Blood Cancers

AbbVie: Increased Outlook For 2025 And Expansions Merit Continued "Strong Buy" Rating

Dec 1, 2025, 5:55 AM EST - 5 weeks ago

AbbVie: Increased Outlook For 2025 And Expansions Merit Continued "Strong Buy" Rating

Best Dividend Aristocrats For December 2025

Nov 29, 2025, 8:02 AM EST - 5 weeks ago

Best Dividend Aristocrats For December 2025

ABT ADM ADP AFL ALB AMCR AOS

SKYRIZI® (risankizumab) Receives Positive Reimbursement Recommendation by Canada's Drug Agency for Ulcerative Colitis and AbbVie Concludes Letter of Intent with the pan-Canadian Pharmaceutical Alliance

Nov 28, 2025, 7:01 AM EST - 5 weeks ago

SKYRIZI® (risankizumab) Receives Positive Reimbursement Recommendation by Canada's Drug Agency for Ulcerative Colitis and AbbVie Concludes Letter of Intent with the pan-Canadian Pharmaceutical Alliance

AbbVie and adMare BioInnovations Foster Life Sciences Innovation with the Launch of the AbbVie Biotech Innovators Award in Quebec

Nov 25, 2025, 9:30 AM EST - 6 weeks ago

AbbVie and adMare BioInnovations Foster Life Sciences Innovation with the Launch of the AbbVie Biotech Innovators Award in Quebec

AbbVie to Present at the Piper Sandler 37th Annual Healthcare Conference

Nov 24, 2025, 8:00 AM EST - 6 weeks ago

AbbVie to Present at the Piper Sandler 37th Annual Healthcare Conference

AbbVie Announces U.S. FDA Approval of EPKINLY® (epcoritamab-bysp) in Combination with Rituximab and Lenalidomide for Relapsed or Refractory Follicular Lymphoma

Nov 18, 2025, 12:47 PM EST - 7 weeks ago

AbbVie Announces U.S. FDA Approval of EPKINLY® (epcoritamab-bysp) in Combination with Rituximab and Lenalidomide for Relapsed or Refractory Follicular Lymphoma

It's Best Time In 10 Years To Lock In Income: Our Picks

Nov 18, 2025, 9:00 AM EST - 7 weeks ago

It's Best Time In 10 Years To Lock In Income: Our Picks

ADC AVGO DG ENB EPD FDX MSFT

Global drugmakers rush to boost US presence as tariff threat looms

Nov 18, 2025, 8:25 AM EST - 7 weeks ago

Global drugmakers rush to boost US presence as tariff threat looms

AMGN AZN BIIB GILD GSK JNJ LLY

AbbVie Inc. (ABBV) Presents at 7th Annual Healthcare Symposium Transcript

Nov 14, 2025, 4:31 PM EST - 7 weeks ago

AbbVie Inc. (ABBV) Presents at 7th Annual Healthcare Symposium Transcript

Biopharma companies have confidence in their ability to do deals: BMO's Evan Seigerman

Nov 14, 2025, 3:19 PM EST - 7 weeks ago

Biopharma companies have confidence in their ability to do deals: BMO's Evan Seigerman

AZN JNJ LLY MRK NVO PFE XLV

AbbVie Announces 20 Recipients of Migraine Career Catalyst Award™

Nov 13, 2025, 8:30 AM EST - 7 weeks ago

AbbVie Announces 20 Recipients of Migraine Career Catalyst Award™

AbbVie Shares Rise To Intraday High After Key Trading Signal

Nov 12, 2025, 3:06 PM EST - 7 weeks ago

AbbVie Shares Rise To Intraday High After Key Trading Signal

Chiesi Group Enters into an Exclusive License Agreement with Aliada Therapeutics, a Wholly Owned Subsidiary of AbbVie, to Advance Blood-Brain Barrier-Crossing Platform Technology in Lysosomal Storage Disorders

Nov 12, 2025, 8:30 AM EST - 2 months ago

Chiesi Group Enters into an Exclusive License Agreement with Aliada Therapeutics, a Wholly Owned Subsidiary of AbbVie, to Advance Blood-Brain Barrier-Crossing Platform Technology in Lysosomal Storage Disorders

Allergan Aesthetics Unveils New Data at 2025 American Society for Dermatologic Surgery Annual Meeting Showcasing Transformative Innovation and Portfolio Excellence

Nov 12, 2025, 8:30 AM EST - 2 months ago

Allergan Aesthetics Unveils New Data at 2025 American Society for Dermatologic Surgery Annual Meeting Showcasing Transformative Innovation and Portfolio Excellence

AbbVie Has Many Bullish Attributes (Technical Analysis)

Nov 11, 2025, 10:40 PM EST - 2 months ago

AbbVie Has Many Bullish Attributes (Technical Analysis)

Healthcare Q3 Dividend Roundup: I Prefer AbbVie Over Pfizer

Nov 8, 2025, 6:38 AM EST - 2 months ago

Healthcare Q3 Dividend Roundup: I Prefer AbbVie Over Pfizer

PFE

Biotech is back. Here's why these rallying stocks belong in your portfolio now.

Nov 3, 2025, 9:58 AM EST - 2 months ago

Biotech is back. Here's why these rallying stocks belong in your portfolio now.

ALNY AMGN BMY LLY MBX MDGL MEDI

ADP, Snap-on Lead 14 Companies To Announce Annual Increases In First Half Of November

Nov 1, 2025, 11:15 PM EDT - 2 months ago

ADP, Snap-on Lead 14 Companies To Announce Annual Increases In First Half Of November

ADP AEP AIZ AOS ATO BDX BRO

Best Dividend Aristocrats For November 2025

Nov 1, 2025, 10:25 AM EDT - 2 months ago

Best Dividend Aristocrats For November 2025

ABT ADM ADP AMCR AOS ATO BDX

AbbVie Inc. (ABBV) Q3 2025 Earnings Call Transcript

Oct 31, 2025, 3:56 PM EDT - 2 months ago

AbbVie Inc. (ABBV) Q3 2025 Earnings Call Transcript

AbbVie Raises 2025 Outlook Helped By Strong Immunology Growth, Boost Dividend

Oct 31, 2025, 11:47 AM EDT - 2 months ago

AbbVie Raises 2025 Outlook Helped By Strong Immunology Growth, Boost Dividend

AbbVie: Why Q3 Confirms Its Immunology Dominance

Oct 31, 2025, 10:39 AM EDT - 2 months ago

AbbVie: Why Q3 Confirms Its Immunology Dominance

AbbVie Lifts Profit Outlook as Sales Rise

Oct 31, 2025, 8:42 AM EDT - 2 months ago

AbbVie Lifts Profit Outlook as Sales Rise

AbbVie Beats Third-Quarter Estimates. There's More to the Drugmaker's Earnings.

Oct 31, 2025, 8:20 AM EDT - 2 months ago

AbbVie Beats Third-Quarter Estimates. There's More to the Drugmaker's Earnings.

AbbVie lifts annual profit forecast on resilient demand for newer immunology drugs

Oct 31, 2025, 7:54 AM EDT - 2 months ago

AbbVie lifts annual profit forecast on resilient demand for newer immunology drugs

AbbVie Reports Third-Quarter 2025 Financial Results

Oct 31, 2025, 7:49 AM EDT - 2 months ago

AbbVie Reports Third-Quarter 2025 Financial Results

The One & Only BOTOX® Cosmetic (onabotulinumtoxinA) Day Returns November 19 with the Biggest Celebration of the Year

Oct 29, 2025, 5:00 PM EDT - 2 months ago

The One & Only BOTOX® Cosmetic (onabotulinumtoxinA) Day Returns November 19 with the Biggest Celebration of the Year

AbbVie Announces Positive Topline Results from Phase 3 Pivotal Studies Evaluating Upadacitinib (RINVOQ®) in Adults and Adolescents with Vitiligo

Oct 29, 2025, 8:11 AM EDT - 2 months ago

AbbVie Announces Positive Topline Results from Phase 3 Pivotal Studies Evaluating Upadacitinib (RINVOQ®) in Adults and Adolescents with Vitiligo

Best Dividend Kings: October 2025

Oct 29, 2025, 5:11 AM EDT - 2 months ago

Best Dividend Kings: October 2025

ABM ABT ADM ADP AWR BDX BKH

AbbVie: Deep Discount Before Earnings

Oct 28, 2025, 11:28 AM EDT - 2 months ago

AbbVie: Deep Discount Before Earnings

Healthy Returns: What to expect from Eli Lilly, Merck, Gilead and AbbVie third-quarter earnings

Oct 28, 2025, 10:40 AM EDT - 2 months ago

Healthy Returns: What to expect from Eli Lilly, Merck, Gilead and AbbVie third-quarter earnings

GILD LLY MRK

Final Trades: Abbvie, Qualcomm, Aptiv, and Palo Alto Networks

Oct 21, 2025, 2:27 PM EDT - 2 months ago

Final Trades: Abbvie, Qualcomm, Aptiv, and Palo Alto Networks

APTV PANW QCOM

cb5000calls
cb5000calls Jan. 7 at 8:12 PM
Speculation: $ABBV buys $RVMD because they already know $PFE has $SLS all but locked up behind closed doors. $XBI
0 · Reply
OptionsKing88
OptionsKing88 Jan. 7 at 8:11 PM
$SLS Abbvie $ABBV is in plans to buy $RVMD and the stock went up by 25% this afternoon. Another clinical stage Oncology company buyout, when is ours. Waiting waiting and still waiting Extremely
0 · Reply
xtremdelt8
xtremdelt8 Jan. 7 at 8:11 PM
$ABBV LOL. Who sold yesterday?
0 · Reply
SparklingGreen
SparklingGreen Jan. 7 at 8:10 PM
$ABBV usually the buyer goes down and the buyee goes up.
0 · Reply
JFais
JFais Jan. 7 at 8:10 PM
$RVMD- known for being a major player in KRAS-driven cancers and specifically pancreatic cancer, +22% on nearing a deal with $ABBV Stock is up 3x since summer lows and nearing a whopping $19 billion market cap Pre-JPM fireworks continues $XBI
0 · Reply
StocktwitsNews
StocktwitsNews Jan. 7 at 8:07 PM
Revolution Medicines Stock Soars On Report Of AbbVie Takeover $RVMD $ABBV https://stocktwits.com/news/equity/markets/revolution-medicines-stock-soars-on-report-of-abbvie-takeover/cmxzObIR42q
0 · Reply
SteeCo
SteeCo Jan. 7 at 8:04 PM
$ALT Biotech heating up. I can’t remember a kick off into the new year with so many takeovers within first days. Even before JPM Things are cooking and biotech in uplift due to such news $TGTX $RVMD $ABBV $SNY https://www.reuters.com/business/healthcare-pharmaceuticals/abbvie-talks-buy-biotech-revolution-medicines-wsj-reports-2026-01-07/
0 · Reply
Runmaster83
Runmaster83 Jan. 7 at 8:03 PM
$ABBV $IBRX $RVMD $XBI Thanks!
0 · Reply
Buzzdaq
Buzzdaq Jan. 7 at 8:02 PM
$ABBV sto Jan30 230cc @ 10.00 (cash raise...)
0 · Reply
OffHisGame88
OffHisGame88 Jan. 7 at 8:01 PM
$ABBV they'll announce the buyout at JP Morgan next week. Word is out on the street
0 · Reply
OptionRunners
OptionRunners Jan. 7 at 8:01 PM
$ABBV also ripping on the buyout news. These are up to about $18 now
0 · Reply
ASAP17
ASAP17 Jan. 7 at 8:01 PM
Entire biotech sector $IBB $XBI going vertical intraday on this $ABBV $RVMD deal. There's so much chasing first, ask questions later thesedays. https://x.com/i/status/2008989402887016723
0 · Reply
fwbavp
fwbavp Jan. 7 at 8:00 PM
$IBRX XBI up on news that $ABBV is looking to buy $RVMD, a clinical-stage precision oncology company that develops novel targeted therapies for RAS-addicted cancers, with a research and development pipeline of RAS(ON) inhibitors and RAS companion inhibitors designed for monotherapy or combination treatment strategies. Obviously good for $XBI, especially oncology companies like $IBRX. https://www.wsj.com/business/deals/abbvie-near-deal-for-revolution-medicines-eca830a1?gaa_at=eafs&gaa_n=AWEtsqf3R7Hv9uAg6y0OlVPiTOdx2UdmIFNZUWunZngQVCpaE2OMgi4iVvZ4t8NPADk%3D&gaa_ts=695ebe28&gaa_sig=TOl2MA7E2jUtxFTUO5Xim3WjkdIx6OTS2QXo5cM8Q5F--PD2NONbCTJWMOxLXj6bUKeO_RC-w2xRLo7sH70qnw%3D%3D
0 · Reply
senseidragon
senseidragon Jan. 7 at 7:58 PM
$RVMD $ABBV holy shit
0 · Reply
OptionRunners
OptionRunners Jan. 7 at 7:57 PM
$EWTX $XBI bunch of biotechs moving higher after the $ABBV $RVMD buyout news
0 · Reply
PanicSeller8
PanicSeller8 Jan. 7 at 7:57 PM
$ABBV Market likes $RVMD rumor.
0 · Reply
OptionRunners
OptionRunners Jan. 7 at 7:50 PM
$RVMD $ABBV buyout
0 · Reply
2dollartrader
2dollartrader Jan. 7 at 5:46 PM
$ABBV I had a postion and added more last week. Can someone explain why this crashed 4% and then made a V shape and then some? Wow
0 · Reply
snaches
snaches Jan. 7 at 4:53 PM
$ABBV
0 · Reply
crtlabz
crtlabz Jan. 7 at 4:48 PM
$ABBV being bought up nicely!
0 · Reply
ROCKSTAR_X
ROCKSTAR_X Jan. 7 at 4:20 PM
$ABBV Should be higher...
0 · Reply
Gps_100X_ROI_Potential
Gps_100X_ROI_Potential Jan. 7 at 3:37 PM
$SLS The Smart Money already knows all of this, I've posting DD for Retail the last 2 days - to catch anyone interested, up. -- ABVX-- is the way this'll go. Bottom Line: it is Confirmed GPS is for Sure Getting FDA Approval - the Institutional Funds know this / Big Pharma Knows this - $ABBV $BMY $RHHBY Certainly Know how their Drugs work and don't work. Short Manipulation w Market Maker assist to Fleece Ignorant Retail - who've had a NICE RUN this Year and this month - Hoping People wont' realize these $4 Shares are Worth $40 In an instant - and 4x that when the P3 data Drops.
0 · Reply